d-Dimer elevation and adverse outcomes

Research output: Contribution to journalArticle

Authors

  • Rim Halaby
  • Christopher J. Popma
  • Ander Cohen
  • Gerald Chi
  • Marcelo Rodrigues Zacarkim
  • Gonzalo Romero
  • Samuel Z. Goldhaber
  • Russell Hull
  • Adrian Hernandez
  • Robert Mentz
  • Robert Harrington
  • Frank Peacock
  • James Welker
  • Ignacio Martin-loeches
  • Yazan Daaboul
  • Serge Korjian
  • C. Michael Gibson

Colleges, School and Institutes

Abstract

d-Dimer is a biomarker of fibrin formation and degradation. While a d-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability of venous thromboembolism (VTE), the prognostic association of an elevated d-dimer with adverse outcomes has received far less emphasis. An elevated d-dimer is independently associated with an increased risk for incident VTE, recurrent VTE, and mortality. An elevated d-dimer is an independent correlate of increased mortality and subsequent VTE across a broad variety of disease states. Therefore, medically ill subjects in whom the d-dimer is elevated constitute a high risk subgroup in which the prospective evaluation of the efficacy and safety of antithrombotic therapy is warranted.

Details

Original languageEnglish
JournalJournal of thrombosis and thrombolysis
Publication statusPublished - 9 Jul 2014